Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

846
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
846
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

8.1K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

971
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
971
Accessory Structures of the Eye01:17

Accessory Structures of the Eye

2.9K
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Impact of Workflow Modifications in an Electronic Medical Record on Tertiary Service Referrals for Patients with Visual Impairment in New York City [Response to Letter].

Clinical ophthalmology (Auckland, N.Z.)·2025
Same author

Enabling Auto-Correction on Soft Braille Keyboard.

Proceedings of the ACM Symposium on User Interface Software and Technology. ACM Symposium on User Interface Software and Technology·2025
Same author

The Impact of Workflow Modifications in an Electronic Medical Record on Tertiary Service Referrals for Patients with Visual Impairment in New York City.

Clinical ophthalmology (Auckland, N.Z.)·2025
Same author

Association of Behavioral Factors with Activation in Patients with Age-Related Macular Degeneration or Diabetic Retinopathy.

Clinical ophthalmology (Auckland, N.Z.)·2025
Same author

The BLV App Arcade: a new curated repository and evaluation rubric for mobile applications supporting blindness and low vision.

Disability and rehabilitation. Assistive technology·2023
Same author

Activation in individuals with vision loss.

Journal of health psychology·2020
Same journal

Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same journal

Ophthalmic Implications of Ehlers-Danlos Syndrome.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same journal

Diagnostic Value of Pupil Involvement and Yield of Vascular Imaging in Isolated Third Cranial Nerve Palsy: A 10-Year Retrospective Study.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same journal

Short-Term Preliminary Results of Outcomes with and without Tenonectomy During Open Conjunctival XEN45 Gel Stent Implantation.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same journal

Chemical and Thermal Ocular Burns in Children: A Retrospective Single-Center Study of Etiology, Clinical Characteristics, and Outcomes.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same journal

Two-Year Follow-Up of the MINI WELL Non-Diffractive Extended Depth-of-Focus Intraocular Lens: A Retrospective Observational Study.

Clinical ophthalmology (Auckland, N.Z.)·2026
See all related articles

Related Experiment Video

Updated: Dec 1, 2025

Subjective Refraction Test Using a Smartphone for Vision Screening
05:36

Subjective Refraction Test Using a Smartphone for Vision Screening

Published on: October 18, 2024

1.4K

Decreasing Avoidable Vision Loss: Identifying Antecedents of Adherence.

Alan R Morse1,2, William H Seiple1,3

  • 1Lighthouse Guild, New York, NY, USA.

Clinical Ophthalmology (Auckland, N.Z.)
|November 11, 2020
PubMed
Summary
This summary is machine-generated.

Medication adherence and patient engagement are vital for managing vision loss and preventing further sight deterioration. Understanding patient barriers can improve treatment effectiveness and outcomes.

Keywords:
AMDactivationadherenceavoidable vision lossdiabetic eye diseaseengagementglaucomapatient activationpatient engagement

More Related Videos

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.4K
Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
07:12

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

725

Related Experiment Videos

Last Updated: Dec 1, 2025

Subjective Refraction Test Using a Smartphone for Vision Screening
05:36

Subjective Refraction Test Using a Smartphone for Vision Screening

Published on: October 18, 2024

1.4K
Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.4K
Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
07:12

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

725

Area of Science:

  • Ophthalmology
  • Public Health
  • Health Psychology

Background:

  • Patient adherence to medical advice and active participation in care are critical, particularly for individuals with chronic conditions like vision loss.
  • Nonadherence can lead to reduced treatment efficacy, increased complications, and poorer health outcomes, including avoidable vision loss.
  • Factors contributing to nonadherence include poor understanding of condition importance, low health literacy, insufficient self-efficacy, low patient activation, and behavioral issues like depression.

Purpose of the Study:

  • To explore the understudied area of patient activation and its role in health management for individuals with vision loss.
  • To identify factors influencing medication adherence and patient engagement in the context of vision loss.
  • To inform the development of targeted strategies to reduce avoidable vision loss by improving adherence and participation.

Main Methods:

  • This study reviews existing literature on patient adherence, health literacy, self-efficacy, and patient activation in chronic disease management, with a focus on vision loss.
  • Analysis involves examining the relationship between patient-reported barriers and adherence to treatment protocols and appointment schedules.
  • The research synthesizes information to identify key antecedents impacting patient engagement and self-management.

Main Results:

  • Lack of information regarding condition prognosis, treatment alternatives, and self-monitoring strategies significantly impedes patient engagement.
  • Low health literacy, inadequate self-efficacy, and depression are identified as significant barriers to adherence and active participation in care.
  • Patient activation, defined as the ability to manage one's own healthcare, has been insufficiently studied in the context of vision loss.

Conclusions:

  • Improving patient understanding, health literacy, and self-efficacy is essential for enhancing adherence and active participation in managing vision loss.
  • Addressing behavioral factors such as depression can mitigate nonadherence.
  • Identifying specific barriers to adherence and activation can lead to personalized interventions that reduce avoidable vision loss and improve patient outcomes.